rs17164935
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001256545.2(MEGF10):c.3215G>A(p.Arg1072Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.156 in 1,613,490 control chromosomes in the GnomAD database, including 20,250 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001256545.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MEGF10 | NM_001256545.2 | c.3215G>A | p.Arg1072Lys | missense_variant | 24/25 | ENST00000503335.7 | NP_001243474.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MEGF10 | ENST00000503335.7 | c.3215G>A | p.Arg1072Lys | missense_variant | 24/25 | 1 | NM_001256545.2 | ENSP00000423354.2 | ||
MEGF10 | ENST00000274473.6 | c.3215G>A | p.Arg1072Lys | missense_variant | 25/26 | 1 | ENSP00000274473.6 | |||
MEGF10 | ENST00000515622.1 | n.416G>A | non_coding_transcript_exon_variant | 4/5 | 2 | |||||
MEGF10 | ENST00000510828.5 | n.*28G>A | downstream_gene_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.141 AC: 21417AN: 152038Hom.: 1556 Cov.: 32
GnomAD3 exomes AF: 0.138 AC: 34687AN: 250580Hom.: 2659 AF XY: 0.140 AC XY: 18988AN XY: 135482
GnomAD4 exome AF: 0.158 AC: 230230AN: 1461334Hom.: 18690 Cov.: 32 AF XY: 0.157 AC XY: 113846AN XY: 726972
GnomAD4 genome AF: 0.141 AC: 21448AN: 152156Hom.: 1560 Cov.: 32 AF XY: 0.138 AC XY: 10282AN XY: 74378
ClinVar
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 05, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
MEGF10-related myopathy Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at